PA
CERE
Perceptive Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,794,876
| Closed | -$441M | – | 123 |
|
|
2024
Q2 | $441M | Hold |
10,794,876
| – | – | 10.63% | 1 |
|
|
2024
Q1 | $456M | Sell |
10,794,876
-170,317
| -2% | -$7.2M | 7.98% | 1 |
|
|
2023
Q4 | $465M | Buy |
10,965,193
+876,808
| +9% | +$37.2M | 10.38% | 1 |
|
|
2023
Q3 | $220M | Hold |
10,088,385
| – | – | 7.35% | 2 |
|
|
2023
Q2 | $321M | Buy |
10,088,385
+3,576,658
| +55% | +$114M | 9.28% | 2 |
|
|
2023
Q1 | $159M | Hold |
6,511,727
| – | – | 4.69% | 4 |
|
|
2022
Q4 | $205M | Hold |
6,511,727
| – | – | 5.77% | 4 |
|
|
2022
Q3 | $184M | Buy |
6,511,727
+1,425,000
| +28% | +$40.3M | 5.34% | 3 |
|
|
2022
Q2 | $134M | Hold |
5,086,727
| – | – | 4.21% | 4 |
|
|
2022
Q1 | $178M | Hold |
5,086,727
| – | – | 3.57% | 8 |
|
|
2021
Q4 | $165M | Hold |
5,086,727
| – | – | 2.54% | 10 |
|
|
2021
Q3 | $150M | Buy |
5,086,727
+443,632
| +10% | +$13.1M | 2.18% | 11 |
|
|
2021
Q2 | $119M | Hold |
4,643,095
| – | – | 1.54% | 18 |
|
|
2021
Q1 | $63.7M | Buy |
4,643,095
+99,033
| +2% | +$1.36M | 0.81% | 30 |
|
|
2020
Q4 | $75.3M | Buy |
+4,544,062
| New | +$75.3M | 0.81% | 35 |
|